Sign In
Buy ANIX
$2.52
-0.0300 (-1.18%)
At Close: Jun 03, 2026
Top Ranked Momentum Stocks to Buy for February 11th
12:16pm, Tuesday, 11'th Feb 2020
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, February 11th.
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 13.) Arvinas Inc (NASDAQ: ARVN ) Baxter Int
Anixa Biosciences Announces Presentation at AACR Liquid Biopsies Conference
12:00pm, Monday, 06'th Jan 2020
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that data from studies utilizing Cchek™, t
Investors Who Bought Anixa Biosciences (NASDAQ:ANIX) Shares Three Years Ago Are Now Down 38%
10:25am, Thursday, 02'nd Jan 2020
It's nice to see the Anixa Biosciences, Inc. (NASDAQ:ANIX) share price up 14% in a week. But that cannot eclipse the...
Anixa Biosciences to Present at Biotech Showcase 2020
12:00pm, Monday, 23'rd Dec 2019
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that its chief executive officer, Dr. Amit K
Anixa Biosciences Announces Commercial Launch of Cchek™ Prostate Cancer Confirmatory Test
11:45am, Monday, 16'th Dec 2019
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced the commercial launch of its Cchek™ Prosta
Anixa Biosciences to Host Conference Call to Discuss Plans for 2020
10:45pm, Friday, 13'th Dec 2019
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that it will hold a conference call on Decem
Anixa Biosciences Provides Update on CAR-T Program
11:45am, Friday, 13'th Dec 2019
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced an update regarding the chimeric antigen rec
Anixa Biosciences Announces Presentation at the 2019 San Antonio Breast Cancer Symposium
12:00pm, Monday, 02'nd Dec 2019
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that data from its ongoing studies utilizing
Anixa Biosciences Announces Genesis Research to Join Cchek™ Prostate Cancer Study
12:00pm, Tuesday, 26'th Nov 2019
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced the addition of Genesis Research, LLC to the
Anixa Biosciences Announces Collaboration with Urology Centers of Alabama on Cchek™ Prostate Cancer Study
12:00pm, Friday, 22'nd Nov 2019
SAN JOSE, Calif., Nov. 22, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced a c
Anixa Biosciences Announces Collaboration with Idaho Urologic Institute on Cchek™ Prostate Cancer Study
12:00pm, Wednesday, 20'th Nov 2019
SAN JOSE, Calif. , Nov. 20, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today ann
